Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Micromanaging alternative splicing during muscle differentiation.

Christopher S Bland1, Thomas A Cooper

  • 1Department of Pathology, Baylor College of Medicine, Houston, TX 77030, USA.

Developmental Cell
|February 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Criteria Clinicians Use to Classify Patients as High Risk in Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.

Advances in therapy·2026
Same author

Real-World Treatment Patterns for Patients with High-Risk Biochemically Recurrent Nonmetastatic Castration‑Sensitive Prostate Cancer.

Advances in therapy·2026
Same author

Developing endpoints for the cardiac burden in myotonic dystrophy type 1: A workshop report.

Journal of neuromuscular diseases·2026
Same author

Progressive cardiac phenotypes and reduced reversibility from long-term CUGexp RNA expression in a DM1 mouse model.

JCI insight·2026
Same author

MBNL loss of function in smooth muscle as a model for myotonic dystrophy associated gastrointestinal dysmotility.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

MBNL overexpression rescues cardiac phenotypes in a myotonic dystrophy type 1 heart mouse model.

The Journal of clinical investigation·2025

Muscle-specific microRNAs (miRNAs) control skeletal muscle development by downregulating the alternative splicing regulator nPTB. This study reveals how posttranscriptional regulation orchestrates crucial splicing transitions during differentiation.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Genetics

Background:

  • Skeletal muscle differentiation involves complex regulatory mechanisms controlling gene expression.
  • Alternative splicing plays a critical role in generating protein diversity during development.
  • MicroRNAs (miRNAs) are key regulators of posttranscriptional gene silencing.

Discussion:

  • Boutz et al. (2007) identified a network of splicing transitions regulated during skeletal muscle development.
  • The study highlights the interplay between miRNAs and splicing factors in directing cell fate.
  • Downregulation of nPTB by muscle-specific miRNAs is a critical step in this process.

Key Insights:

  • Muscle-specific miRNAs directly target and reduce levels of the alternative splicing regulator nPTB.

Related Experiment Videos

  • This downregulation is essential for initiating and executing specific splicing events during myogenesis.
  • The coordinated action of miRNAs and splicing factors ensures proper skeletal muscle formation.

    • Outlook:

    • Further investigation into the broader network of miRNA-regulated splicing in muscle development.
    • Exploring therapeutic potential of modulating miRNA-splicing factor interactions for muscle disorders.
    • Understanding how these regulatory layers contribute to tissue homeostasis and regeneration.